The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

March 23, 2017 – Proove Release: Proove CEO to Speak at 8 th Annual Life Sciences CEO Forum

by | February 12, 2018 | Press Releases | 0 Comments

Brian Meshkin will moderate a panel on "Delivering on the Promise of Precision Medicine" and participate in a panel on "The Convergence of Technology & Healthcare" IRVINE, Calif., March 23, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its founder and...
Read More

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

by | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences' Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...
Read More

May 31, 2017 – Proove Release: Preliminary Results from Large Clinical Utility Study of Over 27,000 Patients Shows 90% of Patients Experience Significant Pain Reduction From Decisions Made with Proove Technology

by | February 12, 2018 | Press Releases | 0 Comments

Preliminary Results of 27,659 patients from MOSAIC Trial Demonstrate that Proove® Technology Leads to Better Patient Outcomes IRVINE, Calif., May 31, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces preliminary results at the close of a large patient-centered...
Read More

April 23, 2015 – Proove Release: Proove Biosciences Launches World's First Test To Predict Responders To Commonly Prescribed Non-Opioid Pain Medications

by | February 12, 2018 | In the News | 0 Comments

The new Proove Non-Opioid Pain Medication Response profile evaluates genetic factors to predict a patient’s response to non opioids before prescribing Irvine, CA (PRWEB) - Proove Biosciences, a commercial and research leader in Personalized Medicine, is excited to...
Read More

April 13, 2016 – Proove Release: Proove and Insurer Specialty Health Announce Positive Coverage Determination for Genetic Testing

by | February 12, 2018 | In the News | 0 Comments

IRVINE, CA and RENO, NV (PRWEB) April 13, 2016 Proove Biosciences and Specialty Health are excited to announce a positive policy decision on the use of Proove Genetic testing to achieve the quadruple aim of improving outcomes, reducing costs, improving patient care,...
Read More

April 7, 2015 – Proove Release: Proove Launches Opioid Response Test

by | February 12, 2018 | Press Releases | 0 Comments

(PRWEB) APRIL 07, 2015 Proove Biosciences a commercial and research leader in Personalized Medicine, is excited to announce the launch of Proove Opioid Response - the world’s first clinical laboratory test to predict responders to opioid pain medications. Building on...
Read More

March 16, 2017 – Proove Release: Key Opinion Leaders Present Precision Medicine Research from Proove at American Academy of Pain Medicine Meeting

by | February 12, 2018 | Press Releases | 0 Comments

Proove continues its leadership of precision pain medicine presenting over 100 studies at major medical meetings outlining breakthrough precision medicine research over the past 5 years IRVINE, Calif., March 16, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. is...
Read More

December 7, 2016 – Proove Release: Proove Launches First Precision Medicine Test for TMJ Disorder

by | February 12, 2018 | In the News | 0 Comments

Proove Launches the Only Commercially Available Genetic Analysis Offering Personalized Medical Treatment Recommendations for TMD Sufferers and Insights Into Contributing Causes of Orofacial Pain IRVINE, CA--(Marketwired - Dec 7, 2016) - Proove Biosciences, Inc., the...
Read More

May 4, 2016 – Proove Release: Proove Announces Collaboration with McGill University

by | February 12, 2018 | In the News | 0 Comments

New Agreement Creates Collaborative Framework for Commercializing Laboratory Research to Help Pain Patients Irvine, CA (PRWEB) May 04, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce a strategic...
Read More

July 14, 2015 – Proove Release: Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

by | February 12, 2018 | In the News | 0 Comments

Irvine, CA (PRWEB) July 14, 2015 Proove Biosciences, a commercial and research leader in Personalized Medicine, recently presented data on three ground-breaking scientific studies at the Neurological Disorders Summit in San Francisco, CA. The Neurological Disorders...
Read More

Video’s

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

Get Instant Access to Updates to The Truth about Proove Bio